[go: up one dir, main page]

AU2002336473A1 - Anti-cancer activity of carvedilol and its isomers - Google Patents

Anti-cancer activity of carvedilol and its isomers

Info

Publication number
AU2002336473A1
AU2002336473A1 AU2002336473A AU2002336473A AU2002336473A1 AU 2002336473 A1 AU2002336473 A1 AU 2002336473A1 AU 2002336473 A AU2002336473 A AU 2002336473A AU 2002336473 A AU2002336473 A AU 2002336473A AU 2002336473 A1 AU2002336473 A1 AU 2002336473A1
Authority
AU
Australia
Prior art keywords
carvedilol
isomers
cancer activity
cancer
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002336473A
Inventor
Anand C. Burman
Manu Jaggi
Rama Mukherjee
Anu T. Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dabur Research Foundation
Original Assignee
Dabur Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dabur Research Foundation filed Critical Dabur Research Foundation
Publication of AU2002336473A1 publication Critical patent/AU2002336473A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002336473A 2002-09-10 2002-09-10 Anti-cancer activity of carvedilol and its isomers Abandoned AU2002336473A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/028794 WO2004024145A1 (en) 2002-09-10 2002-09-10 Anti-cancer activity of carvedilol and its isomers

Publications (1)

Publication Number Publication Date
AU2002336473A1 true AU2002336473A1 (en) 2004-04-30

Family

ID=31989874

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002336473A Abandoned AU2002336473A1 (en) 2002-09-10 2002-09-10 Anti-cancer activity of carvedilol and its isomers

Country Status (2)

Country Link
AU (1) AU2002336473A1 (en)
WO (1) WO2004024145A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040127470A1 (en) * 1998-12-23 2004-07-01 Pharmacia Corporation Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist
ZA200803226B (en) * 2005-10-13 2009-11-25 Orchid Res Lab Ltd Heterocyclic Compounds as Pstat3/IL-6 Inhibitors
US9745278B2 (en) * 2007-09-10 2017-08-29 Boston Biomedical, Inc. Group of STAT3 pathway inhibitors and cancer stem cell pathway inhibitors
US11299469B2 (en) 2016-11-29 2022-04-12 Sumitomo Dainippon Pharma Oncology, Inc. Naphthofuran derivatives, preparation, and methods of use thereof
CN111825599A (en) * 2019-04-17 2020-10-27 上海中医药大学附属龙华医院 Medicinal uses of novel Neddylation inhibitors
CN113069447A (en) * 2021-04-20 2021-07-06 上海市肺科医院 Application of carvedilol in preparation of STING agonist and chemotherapy sensitization drugs
CN116509845B (en) * 2022-12-08 2025-03-14 遵义医科大学附属医院 Application of carvedilol in preparation of medicines for treating leukemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334307A (en) * 1996-08-23 2000-11-24 Boehringer Mannheim Pharm Corp Compounds for treating diseases wherein inhibition of Fas-mediated apoptosis is indicated

Also Published As

Publication number Publication date
WO2004024145A1 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
AU2003288902A1 (en) Microcapsules and methods of use
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003236135A1 (en) Aralkyl-alcohol peiperazine derivatives and their uses as antidepressant
AU2003255982A1 (en) Preparation of microcapsules
AU2003230952A1 (en) Treatment of mucositis
AU2003298020A1 (en) Catalytic antioxidants and methods of use
AU2003230566A1 (en) Therapeutic regulation of deoxyribonuclease-1-like-3 activity
AU2003285270A1 (en) Intermetallic material and use of said material
AU2002336473A1 (en) Anti-cancer activity of carvedilol and its isomers
AU2003297612A1 (en) 2-substituted-3-propenamide derivatives and methods of using the same
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003272952A1 (en) Structure of chair backrest
AU2003285686A1 (en) Glycoisoforms of adiponectin and uses thereof
AU2003206872A1 (en) Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
AU2003230064A1 (en) Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2003215246A1 (en) Methods of reducing rhinovirus contagion and related compositions
AU2003258522A1 (en) Jewellery structure with high flexibility of use
AU2003254447A1 (en) Treatment of proliferative disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase